Literature DB >> 20605164

Gene-gene-sex interaction in cytokine gene polymorphisms revealed by serum interferon alpha phenotype in juvenile dermatomyositis.

Timothy B Niewold1, Silvia N Kariuki, Gabrielle A Morgan, Sheela Shrestha, Lauren M Pachman.   

Abstract

OBJECTIVE: To detect genetic polymorphisms associated with high serum interferon alpha (IFN-alpha) levels in juvenile dermatomyositis (JDM) and explore interactions in associated polymorphisms. STUDY
DESIGN: Eighty-five children of European ancestry with definite/probable JDM were studied. Selected genetic polymorphisms that were associated with high IFN-alpha levels in 12 untreated patients with newly diagnosed JDM were genotyped in a validation cohort of 73 children with JDM and analyzed for gene-gene and gene-sex interactions.
RESULTS: Untreated children with newly diagnosed JDM carrying both the osteopontin (OPN) rs28357094G and tumor necrosis factor alpha (TNF-alpha)-308 A alleles had significantly increased serum IFN-alpha levels. These 2 polymorphisms were genotyped in the validation cohort, and the OPN rs28357094G allele was more common in female subjects with JDM (odds ratio=3.97, P=.012). This OPN allele was most strongly enriched in female carriers of TNF-alpha-308A as compared with male carriers of TNF-alpha-308A (odds ratio>9.0; P=7.2x10(-3)).
CONCLUSION: These data support a complex gene-gene-sex interaction between the OPN and TNF-alpha promoter regions in JDM, defining a high serum IFN-alpha subgroup within JDM. This suggests pathogenic synergy between the OPN and TNF-alpha loci in female subjects with JDM, which may underlie some of the increased incidence of this condition in girls. Copyright (c) 2010 Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20605164      PMCID: PMC2936662          DOI: 10.1016/j.jpeds.2010.04.034

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  34 in total

Review 1.  Polymyositis and dermatomyositis (first of two parts).

Authors:  A Bohan; J B Peter
Journal:  N Engl J Med       Date:  1975-02-13       Impact factor: 91.245

2.  Genetic variation at the IRF7/PHRF1 locus is associated with autoantibody profile and serum interferon-alpha activity in lupus patients.

Authors:  Rafah Salloum; Beverly S Franek; Silvia N Kariuki; Lesley Rhee; Rachel A Mikolaitis; Meenakshi Jolly; Tammy O Utset; Timothy B Niewold
Journal:  Arthritis Rheum       Date:  2010-02

3.  Joint analysis is more efficient than replication-based analysis for two-stage genome-wide association studies.

Authors:  Andrew D Skol; Laura J Scott; Gonçalo R Abecasis; Michael Boehnke
Journal:  Nat Genet       Date:  2006-01-15       Impact factor: 38.330

4.  Activation of the type I interferon system in primary Sjögren's syndrome: a possible etiopathogenic mechanism.

Authors:  Ullvi Båve; Gunnel Nordmark; Tanja Lövgren; Johan Rönnelid; Stefan Cajander; Maija-Leena Eloranta; Gunnar V Alm; Lars Rönnblom
Journal:  Arthritis Rheum       Date:  2005-04

5.  Activation of the interferon-alpha pathway identifies a subgroup of systemic lupus erythematosus patients with distinct serologic features and active disease.

Authors:  Kyriakos A Kirou; Christina Lee; Sandhya George; Kyriakos Louca; Margaret G E Peterson; Mary K Crow
Journal:  Arthritis Rheum       Date:  2005-05

6.  T-bet-dependent expression of osteopontin contributes to T cell polarization.

Authors:  Mari L Shinohara; Marianne Jansson; Eun Sook Hwang; Miriam B F Werneck; Laurie H Glimcher; Harvey Cantor
Journal:  Proc Natl Acad Sci U S A       Date:  2005-11-14       Impact factor: 11.205

7.  TNFalpha-308A allele in juvenile dermatomyositis: association with increased production of tumor necrosis factor alpha, disease duration, and pathologic calcifications.

Authors:  L M Pachman; M R Liotta-Davis; D K Hong; T R Kinsella; E P Mendez; J M Kinder; E H Chen
Journal:  Arthritis Rheum       Date:  2000-10

8.  Molecular genetic studies of major histocompatibility complex genes in children with juvenile dermatomyositis: increased risk associated with HLA-DQA1 *0501.

Authors:  A M Reed; L Pachman; C Ober
Journal:  Hum Immunol       Date:  1991-12       Impact factor: 2.850

9.  Immune interferon in the circulation of patients with autoimmune disease.

Authors:  J J Hooks; H M Moutsopoulos; S A Geis; N I Stahl; J L Decker; A L Notkins
Journal:  N Engl J Med       Date:  1979-07-05       Impact factor: 91.245

10.  Two single-nucleotide polymorphisms in the 5' and 3' ends of the osteopontin gene contribute to susceptibility to systemic lupus erythematosus.

Authors:  S D'Alfonso; N Barizzone; M Giordano; A Chiocchetti; C Magnani; L Castelli; M Indelicato; F Giacopelli; M Marchini; R Scorza; M G Danieli; M Cappelli; S Migliaresi; B Bigliardo; M G Sabbadini; E Baldissera; M Galeazzi; G D Sebastiani; G Minisola; R Ravazzolo; U Dianzani; P Momigliano-Richiardi
Journal:  Arthritis Rheum       Date:  2005-02
View more
  22 in total

1.  Juvenile dermatomyositis: new insights and new treatment strategies.

Authors:  Neil Martin; Charles K Li; Lucy R Wedderburn
Journal:  Ther Adv Musculoskelet Dis       Date:  2012-02       Impact factor: 5.346

Review 2.  Sex Differences in Pediatric Rheumatology.

Authors:  Marco Cattalini; Martina Soliani; Maria Costanza Caparello; Rolando Cimaz
Journal:  Clin Rev Allergy Immunol       Date:  2019-06       Impact factor: 8.667

Review 3.  Advances in Juvenile Dermatomyositis: Myositis Specific Antibodies Aid in Understanding Disease Heterogeneity.

Authors:  Lauren M Pachman; Amer M Khojah
Journal:  J Pediatr       Date:  2018-04       Impact factor: 4.406

4.  Sex differential association of dermatomyositis with Sjögren syndrome.

Authors:  Chia-Chun Tseng; Shun-Jen Chang; Wen-Chan Tsai; Tsan-Teng Ou; Cheng-Chin Wu; Wan-Yu Sung; Ming-Chia Hsieh; Jeng-Hsien Yen
Journal:  CMAJ       Date:  2017-02-06       Impact factor: 8.262

Review 5.  Pathogenesis of dermatomyositis: role of cytokines and interferon.

Authors:  Lily Kao; Lorinda Chung; David F Fiorentino
Journal:  Curr Rheumatol Rep       Date:  2011-06       Impact factor: 4.592

6.  Familial aggregation of autoimmune disease in juvenile dermatomyositis.

Authors:  Timothy B Niewold; Stephanie C Wu; Molly Smith; Gabrielle A Morgan; Lauren M Pachman
Journal:  Pediatrics       Date:  2011-04-18       Impact factor: 7.124

7.  Large-scale analysis of tumor necrosis factor α levels in systemic lupus erythematosus.

Authors:  Corinna E Weckerle; Dorothy Mangale; Beverly S Franek; Jennifer A Kelly; Marissa Kumabe; Judith A James; Kathy L Moser; John B Harley; Timothy B Niewold
Journal:  Arthritis Rheum       Date:  2012-09

Review 8.  Type I interferon in rheumatic diseases.

Authors:  Theresa L Wampler Muskardin; Timothy B Niewold
Journal:  Nat Rev Rheumatol       Date:  2018-03-21       Impact factor: 20.543

Review 9.  Immunological biomarkers in dermatomyositis.

Authors:  Jeannette M Olazagasti; Timothy B Niewold; Ann M Reed
Journal:  Curr Rheumatol Rep       Date:  2015-11       Impact factor: 4.592

Review 10.  The type I interferons: Basic concepts and clinical relevance in immune-mediated inflammatory diseases.

Authors:  Consuelo M López de Padilla; Timothy B Niewold
Journal:  Gene       Date:  2015-09-26       Impact factor: 3.688

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.